研究用抗体の市場規模、シェア、動向調査レポート：製品別（一次、二次）、タイプ別、技術別、原材料別、用途別、最終用途別、地域別、セグメント別予測、2022年～2030年

研究用抗体市場の成長と動向

Grand View Research, Inc.の最新レポートによると、研究用抗体の世界市場規模は、2022年から2030年までCAGR4.93%で拡大し、2030年には22億1000万米ドルに達すると予測されています。市場を牽引する要因としては、バイオ医薬品・バイオテクノロジー企業による研究開発活動の活発化や、政府当局からの支援の増加などが挙げられます。さらに、神経生物学や幹細胞調査範囲の拡大、技術的に高度な抗体製造方法の利用が、市場成長の促進要因になると予想されます。

細胞ベースの研究を促進するために、研究機関やさまざまな公共・民間団体が行う共同イニシアチブの数が増加していることが、市場の成長を後押ししています。この動向は、北米のように科学的インフラが確立されている市場でより顕著に見られます。例えば、2020年3月、カナダ政府は、細胞再生に基づく科学的研究の実施に携わる再生医療商業化センターに向けて約430万米ドルの資金を投じました。さらに、2021年4月には、COVID-19のような慢性・重篤な疾患を抱える人々のための情報、治療法、技術の開発とその長期的な影響の評価を目的として、Stem Cell Networkに3年間で4500万米ドルの投資を行うと発表しています。このような取り組みにより、抗体活動のさらなる導入が促進され、市場の成長見通しが高まると期待されます。

COVID-19の発生は、市場に有利な成長機会を生み出しています。いくつかの大手製薬会社は、効果的な検査ツールを作成し、この病気の科学的理解を深めるために研究開発に多額の投資を行っています。新しいワクチン接種や治療技術の開発のためのこうした激しい研究開発の結果、研究用抗体のニーズが大幅に高まっています。さらに、多くの公的機関や商業団体が、COVID-19ワクチンや治療薬の開発資金に大きな力を注いでいます。例えば、2020年4月、バイオ医薬品会社であるEmergent BioSolutionsは、連邦政府から1450万米ドルを受け取り、COVID-19の抗体治療研究に取り組んでいます。

研究用抗体市場レポートハイライト

2021年には、抗体が提供する高い特異性と直接検出能力により、一次製品分野が最大の売上シェアを占めた

タイプ別では、モノクローナル抗体が、そのような抗体の使用を含むCOVID-19関連の研究活動の増加により、2021年にかなりのシェアを獲得した

ウェスタンブロッティング技術セグメントは、複数のバイオテクノロジーおよび製薬企業による研究開発活動への投資の増加、およびプロテオミクス研究用に作成されたウェスタンブロットにおける抗体の用途が急速に拡大していることから、2021年に25.0%以上の圧倒的シェアを獲得した

エンドユーザー別では、資金調達機会の増加やライフサイエンスに携わる科学機関の増加により、学術・研究機関が2021年に60.0%超の最大シェアを占めました。

2021年には、ライフサイエンス研究機関や多数のバイオテクノロジーおよびバイオ医薬品メーカーが広く存在する北米が35.0%超の最大シェアを占めた

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 市場の定義
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報と第三者の視点
  • 1次調査
• 情報分析
  • データ分析モデル
• 市場形成とデータ可視化
• データの検証と公開

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し

第3章 研究用抗体市場の変数、動向、範囲

• 市場系列の見通し
  • 親市場の見通し
  • アンシラリー市場の見通し
• 浸透と成長の見通しのマッピング
• 市場力学
  • 市場促進要因分析
    • 研究開発への投資の増加
    • 幹細胞の増殖と神経生物学の調査
    • 調査アカデミーと業界のコラボレーションの増加
    • 技術的に高度な製品の入手可能性の上昇
    • プロテオミクスとゲノミクス調査の台頭
  • 市場の抑制要因と課題の分析
    • 不確実な政府規制
    • 研究用抗体および時間とコストのかかる抗体開発プロセスに関連する品質上の懸念
  • 市場機会分析
    • 個別化医療に対する需要の高まりとバイオマーカー発見への関心の高まり
    • さまざまな新興市場での機会の増加
• 研究用抗体市場分析ツール
  • 業界分析- ポーターズ
    • サプライヤーの力
    • 買い手の交渉力
    • 代替の脅威
    • 新規参入者からの脅威
    • 競争企業間の敵対関係
  • PESTEL分析
• COVID-19が研究用抗体市場に与える影響

第4章 研究用抗体市場：製品の推定・動向分析

• 定義と範囲
• 製品市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の研究用抗体市場、製品別、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• プライマリー
• セカンダリ

第5章 研究用抗体市場：タイプの推定・動向分析

• 定義と範囲
• タイプ市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の研究用抗体市場、タイプ別、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• モノクローナル抗体
• ポリクローナル抗体

第6章 研究用抗体市場：技術推定・動向分析

• 定義と範囲
• テクノロジー市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 市場、技術別、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• 免疫化学
• 免疫蛍光
• ウェスタンブロッティング
• フローサイトメトリー
• 免疫沈降
• ELISA
• その他の技術

第7章 研究用抗体市場：原材料の推定・動向分析

• 定義と範囲
• ソース市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 市場、ソース別、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• ねずみ
• うさぎ
• ヤギ
• その他の原材料

第8章 研究用抗体市場：アプリケーションの推定・動向分析

• 定義と範囲
• アプリケーション市場シェア分析、2021年および2030年
• セグメントダッシュボード
• アプリケーション別の世界の研究用抗体市場、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• 感染症
• 免疫学
• 腫瘍学
• 幹細胞
• 神経生物学
• その他のアプリケーション

第9章 研究用抗体市場：最終用途の推定・動向分析

• 定義と範囲
• 最終用途の市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 市場、最終用途別、2018年から2030年
• 2018年から2030年までの市場規模と予測、トレンド分析
• 学術・調査機関
• 受託調査機関
• 製薬およびバイオテクノロジー企業

第10章 研究用抗体市場：セグメント分析、地域別、2018年から2030年（100万米ドル）

• 研究用抗体市場：地域動向変動分析、2021年および2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • ロシア
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東およびアフリカ（MEA）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 競合情勢

• 公開会社
  • 会社の市況分析
  • 競合ダッシュボード分析
  • 戦略的枠組み
• プライベートカンパニー
  • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
  • 地域ネットワークマップ
• 企業プロファイル
  • ABCAM PLC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • MERCK KGAA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • THERMO FISHER SCIENTIFIC, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • CELL SIGNALLING TECHNOLOGY, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SANTA CRUZ BIOTECHNOLOGY INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • PERKINELMER, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BECTON, DICKINSON &COMPANY
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BIO-TECHNE CORPORATION
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • PROTEINTECH GROUP, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • JACKSON IMMUNORESEARCH INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Tables
• Table 2 List of Secondary Sources
• Table 3 List of Abbreviations
• Table 4 Global Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 5 Global Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 6 Global Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 7 Global Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 8 Global Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 9 Global Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 10 Global Research Antibodies Market, by Region, 2018 - 2030 (USD Million)
• Table 11 North America Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 12 North America Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 13 North America Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 14 North America Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 15 North America Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 16 North America Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 17 U.S. Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 18 U.S. Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 19 U.S. Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 20 U.S. Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 21 U.S. Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 22 U.S. Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 23 Canada Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 24 Canada Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 25 Canada Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 26 Canada Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 27 Canada Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 28 Canada Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 29 Europe Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 30 Europe Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 31 Europe Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 32 Europe Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 33 Europe Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 34 Europe Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 35 U.K. Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 36 U.K. Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 37 U.K. Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 38 U.K. Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 39 U.K. Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 40 U.K. Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 41 Germany Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Germany Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 43 Germany Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 44 Germany Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 45 Germany Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 46 Germany Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 47 France Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 48 France Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 49 France Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 50 France Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 51 France Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 52 France Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 53 Italy Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Italy Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 55 Italy Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 56 Italy Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 57 Italy Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 58 Italy Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 59 Spain Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Spain Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 61 Spain Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 62 Spain Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 63 Spain Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 64 Spain Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 65 Russia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 66 Russia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 67 Russia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 68 Russia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 69 Russia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Russia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 77 Japan Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Japan Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 79 Japan Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 80 Japan Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 81 Japan Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 82 Japan Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 83 China Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 84 China Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 85 China Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 86 China Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 87 China Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 88 China Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 89 India Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 90 India Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 91 India Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 92 India Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 93 India Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 94 India Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 95 South Korea Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 96 South Korea Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 97 South Korea Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 98 South Korea Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 99 South Korea Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 100 South Korea Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 101 Australia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 102 Australia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 103 Australia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 104 Australia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 105 Australia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 106 Australia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 107 Singapore Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 108 Singapore Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 109 Singapore Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 110 Singapore Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 111 Singapore Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 112 Singapore Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 113 Latin America Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 114 Latin America Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 115 Latin America Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 116 Latin America Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 117 Latin America Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 118 Latin America Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 119 Brazil Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 120 Brazil Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 121 Brazil Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 122 Brazil Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 123 Brazil Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 124 Brazil Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 125 Mexico Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 126 Mexico Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 127 Mexico Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 128 Mexico Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 129 Mexico Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 130 Mexico Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 131 Argentina Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 132 Argentina Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 133 Argentina Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 134 Argentina Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 135 Argentina Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 136 Argentina Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 137 MEA Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 138 MEA Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 139 MEA Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 140 MEA Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 141 MEA Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 142 MEA Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 143 South Africa Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 144 South Africa Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 145 South Africa Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 146 South Africa Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 147 South Africa Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 148 South Africa Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 149 Saudi Arabia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 150 Saudi Arabia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 151 Saudi Arabia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 152 Saudi Arabia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 153 Saudi Arabia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 154 Saudi Arabia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
• Table 155 UAE Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
• Table 156 UAE Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
• Table 157 UAE Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
• Table 158 UAE Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
• Table 159 UAE Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
• Table 160 UAE Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

• Figure 1 Market research process
• Figure 2 Information Procurement
• Figure 3 Primary Research Pattern
• Figure 4 Market Research Approaches
• Figure 5 Value Chain-Based Sizing & Forecasting
• Figure 6 Market Formulation & Validation
• Figure 7 Research Antibodies, Market Segmentation
• Figure 8 Market Snapshot, 2021
• Figure 9 Market Trends & Outlook
• Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
• Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Figure 13 Porter's Five Forces Analysis
• Figure 14 Market Penetration Vs Growth Prospect Mapping, 2021
• Figure 15 Global Research Antibodies Market: Product Movement Analysis
• Figure 16 Global Research Antibodies Market, for Primary, 2018 - 2030 (USD Million)
• Figure 17 Global Research Antibodies Market, for Secondary, 2018 - 2030 (USD Million)
• Figure 18 Global Research Antibodies Market: Type, Movement Analysis
• Figure 19 Global Research Antibodies Market, for Monoclonal Antibodies, 2018 - 2030 (USD Million)
• Figure 20 Global Research Antibodies Market, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
• Figure 21 Global Research Antibodies Market: Technology, Movement Analysis
• Figure 22 Global Research Antibodies Market, for Immunohistochemistry, 2018 - 2030 (USD Million)
• Figure 23 Global Research Antibodies Market, for Immunofluorescence, 2018 - 2030 (USD Million)
• Figure 24 Global Research Antibodies Market, for Western Blotting, 2018 - 2030 (USD Million)
• Figure 25 Global Research Antibodies Market, for Flow Cytometry, 2018 - 2030 (USD Million)
• Figure 26 Global Research Antibodies Market: Immunoprecipitation, Movement Analysis
• Figure 27 Global Research Antibodies Market, for ELISA, 2018 - 2030 (USD Million)
• Figure 28 Global Research Antibodies Market, for Other Technologies, 2018 - 2030 (USD Million)
• Figure 29 Global Research Antibodies Market: Source, Movement Analysis
• Figure 30 Global Research Antibodies Market, for Mouse, 2018 - 2030 (USD Million)
• Figure 31 Global Research Antibodies Market, for Rabbit, 2018 - 2030 (USD Million)
• Figure 32 Global Research Antibodies Market, for Goat, 2018 - 2030 (USD Million)
• Figure 33 Global Research Antibodies Market, for Other Sources, 2018 - 2030 (USD Million)
• Figure 34 Global Research Antibodies Market: Application, Movement Analysis
• Figure 35 Global Research Antibodies Market, for Infectious Diseases, 2018 - 2030 (USD Million)
• Figure 36 Global Research Antibodies Market, for Immunology, 2018 - 2030 (USD Million)
• Figure 37 Global Research Antibodies Market, for Oncology, 2018 - 2030 (USD Million)
• Figure 38 Global Research Antibodies Market, for Stem Cells, 2018 - 2030 (USD Million)
• Figure 39 Global Research Antibodies Market, for Neurobiology, 2018 - 2030 (USD Million)
• Figure 40 Global Research Antibodies Market, for Other Applications, 2018 - 2030 (USD Million)
• Figure 41 Global Research Antibodies Market: End-use, Movement Analysis
• Figure 42 Global Research Antibodies Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
• Figure 43 Global Research Antibodies Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
• Figure 44 Global Research Antibodies Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
• Figure 45 Regional Marketplace: Key Takeaways
• Figure 46 Regional Outlook, 2021 & 2030
• Figure 47 Global Research Antibodies Market: Region Movement Analysis
• Figure 48 North America Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 49 U.S. Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 50 Canada Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 51 Europe Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 52 Germany Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 53 U.K. Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 54 France Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 55 Italy Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 56 Spain Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 57 Russia Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 58 Asia Pacific Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 59 Japan Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 60 China Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 61 India Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 62 Australia Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 63 South Korea Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 64 Singapore Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 65 Latin America Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 66 Brazil Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 67 Mexico Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 68 Argentina Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 69 Middle East and Africa Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 70 South Africa Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 71 Saudi Arabia Research Antibodies Market, 2018 - 2030 (USD Million)
• Figure 72 UAE Research Antibodies Market, 2018 - 2030 (USD Million)

Research Antibodies Market Growth & Trends:

The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.93% from 2022 to 2030, according to a new report by Grand View Research, Inc. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.

An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.

The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.

Research Antibodies Market Report Highlights:

• In 2021, the primary product segment held the largest revenue share due to the higher specificity and direct detection capabilities offered by the antibodies

• By type, monoclonal antibodies captured a substantial share in 2021 due to the increase in COVID-19-related research activities involving the use of such antibodies

• The western blotting technology segment held a dominant share of over 25.0% in 2021 because of the increasing investments in R&D activities by several biotechnology and pharmaceutical companies and the rapidly growing applications of antibodies in western blots created for proteomic studies

• By end-use, academic and research institutions held the largest share of over 60.0% in 2021 due to a rise in funding opportunities and growth in the number of scientific institutions involved in life sciences

• In 2021, North America accounted for the largest share of over 35.0% due to the widespread presence of life sciences research institutions and numerous biotechnology and biopharmaceutical manufacturers in the region

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation & Scope
• 1.2 Market Definition
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources & Third Party Perspectives
  • 1.3.4 Primary Research
• 1.4 Information Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Data Visualization
• 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook

Chapter 3 Research Antibodies Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration And Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Increasing Investment In R&D
    • 3.3.1.2 Growing Stem Cells And Neurobiology Research
    • 3.3.1.3 Increase In Research Academies And Industry Collaborations
    • 3.3.1.4 Rise In The Availability Of Technologically Advanced Products
    • 3.3.1.5 Rise In Proteomics And Genomics Research
  • 3.3.2 Market Restraint and Challenges Analysis
    • 3.3.2.1 Uncertain Government Regulations
    • 3.3.2.2 Quality Concerns associated with research antibodies and time- & cost-intensive process of antibody development
  • 3.3.3 Market Opportunities Analysis
    • 3.3.3.1 Growing demand for Personalized medicine and rising focus on biomarker discovery
    • 3.3.3.2 Increasing opportunities in various emerging markets
• 3.4 Research Antibodies Market Analysis Tools
  • 3.4.1 Industry Analysis - Porter's
    • 3.4.1.1 Supplier Power
    • 3.4.1.2 Buyer Power
    • 3.4.1.3 Substitution Threat
    • 3.4.1.4 Threat From New Entrants
    • 3.4.1.5 Competitive Rivalry
  • 3.4.2 PESTEL Analysis
• 3.5 Covid-19 Impact On Research Antibodies Market

Chapter 4 Research Antibodies Market: Product Estimates And Trend Analysis

• 4.1 Definition & Scope
• 4.2 Product Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Research Antibodies Market, By Product, 2018 To 2030
• 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 4.6 Primary
  • 4.6.1 Primary Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 4.7 Secondary
  • 4.7.1 Secondary Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 5 Research Antibodies Market: Type Estimates And Trend Analysis

• 5.1 Definition & Scope
• 5.2 Type Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Research Antibodies Market, By Type, 2018 To 2030
• 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 5.6 Monoclonal Antibodies
  • 5.6.1 Monoclonal Antibodies Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 5.7 Polyclonal Antibodies
  • 5.7.1 Polyclonal Antibodies Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 6 Research Antibodies Market: Technology Estimates And Trend Analysis

• 6.1 Definition & Scope
• 6.2 Technology Market Share Analysis, 2021 & 2030
• 6.3 Segment Dashboard
• 6.4 Market, By Technology, 2018 To 2030
• 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 6.6 Immunochemistry
  • 6.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.7 Immunofluorescence
  • 6.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.8 Western Blotting
  • 6.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.9 Flow Cytometry
  • 6.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.10 Immunoprecipitation
  • 6.10.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.11 ELISA
  • 6.11.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 6.12 Other Technologies
  • 6.12.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 7 Research Antibodies Market: Source Estimates And Trend Analysis

• 7.1 Definition & Scope
• 7.2 Source Market Share Analysis, 2021 & 2030
• 7.3 Segment Dashboard
• 7.4 Market, By Source, 2018 To 2030
• 7.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 7.6 Mouse
  • 7.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 7.7 Rabbit
  • 7.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 7.8 Goat
  • 7.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 7.9 Other Sources
  • 7.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 8 Research Antibodies Market: Application Estimates And Trend Analysis

• 8.1 Definition & Scope
• 8.2 Application Market Share Analysis, 2021 & 2030
• 8.3 Segment Dashboard
• 8.4 Global Research Antibodies Market, By Application, 2018 To 2030
• 8.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 8.6 Infectious Diseases
  • 8.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 8.7 Immunology
  • 8.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 8.8 Oncology
  • 8.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 8.9 Stem Cells
  • 8.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 8.10 Neurobiology
  • 8.10.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 8.11 Other Applications
  • 8.11.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 9 Research Antibodies Market: End-use Estimates And Trend Analysis

• 9.1 Definition & Scope
• 9.2 End-use Market Share Analysis, 2021 & 2030
• 9.3 Segment Dashboard
• 9.4 Market, By End Use, 2018 To 2030
• 9.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
• 9.6 Academic & Research Institutes
  • 9.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 9.7 Contract Research Organizations
  • 9.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
• 9.8 Pharmaceutical & Biotechnology Companies
  • 9.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 10 Research Antibodies Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 10.1 Research Antibodies Market: Regional Movement Analysis, 2021 & 2030
• 10.2 North America
  • 10.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.2.2 U.S.
    • 10.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.2.3 Canada
    • 10.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 10.3 Europe
  • 10.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3.2 U.K.
    • 10.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.3.3 Germany
    • 10.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3.4 Spain
    • 10.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3.5 France
    • 10.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3.6 Italy
    • 10.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3.7 Russia
    • 10.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 10.4 Asia Pacific
  • 10.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4.2 Japan
    • 10.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4.3 China
    • 10.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4.4 India
    • 10.4.4.1 India Market Estimates And Forecast, 2018 - 2030
  • 10.4.5 South Korea
    • 10.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
  • 10.4.6 Australia
    • 10.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030
  • 10.4.7 Singapore
    • 10.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030
• 10.5 Latin America
  • 10.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5.2 Brazil
    • 10.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5.3 Mexico
    • 10.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5.4 Argentina
    • 10.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 10.6 Middle East & Africa (MEA)
  • 10.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6.2 South Africa
    • 10.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6.3 Saudi Arabia
    • 10.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6.4 UAE
    • 10.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

• 11.1 Public Companies
  • 11.1.1 Company Market Position Analysis
  • 11.1.2 Competitive Dashboard Analysis
  • 11.1.3 Strategic Framework
• 11.2 Private Companies
  • 11.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
  • 11.2.2 Regional Network Map
• 11.3 Company Profiles
  • 11.3.1 ABCAM PLC
    • 11.3.1.1 Company Overview
    • 11.3.1.2 Financial Performance
    • 11.3.1.3 Product Benchmarking
    • 11.3.1.4 Strategic Initiatives
  • 11.3.2 MERCK KGAA
    • 11.3.2.1 Company Overview
    • 11.3.2.2 Financial Performance
    • 11.3.2.3 Product Benchmarking
    • 11.3.2.4 Strategic Initiatives
  • 11.3.3 THERMO FISHER SCIENTIFIC, INC.
    • 11.3.3.1 Company Overview
    • 11.3.3.2 Financial Performance
    • 11.3.3.3 Product Benchmarking
    • 11.3.3.4 Strategic Initiatives
  • 11.3.4 CELL SIGNALLING TECHNOLOGY, INC.
    • 11.3.4.1 Company Overview
    • 11.3.4.2 Financial Performance
    • 11.3.4.3 Product Benchmarking
    • 11.3.4.4 Strategic Initiatives
  • 11.3.5 SANTA CRUZ BIOTECHNOLOGY INC.
    • 11.3.5.1 Company Overview
    • 11.3.5.2 Financial Performance
    • 11.3.5.3 Product Benchmarking
    • 11.3.5.4 Strategic Initiatives
  • 11.3.6 PERKINELMER, INC.
    • 11.3.6.1 Company Overview
    • 11.3.6.2 Financial Performance
    • 11.3.6.3 Product Benchmarking
    • 11.3.6.4 Strategic Initiatives
  • 11.3.7 BECTON, DICKINSON & COMPANY
    • 11.3.7.1 Company Overview
    • 11.3.7.2 Financial Performance
    • 11.3.7.3 Product Benchmarking
    • 11.3.7.4 Strategic Initiatives
  • 11.3.8 BIO-TECHNE CORPORATION
    • 11.3.8.1 Company Overview
    • 11.3.8.2 Financial Performance
    • 11.3.8.3 Product Benchmarking
    • 11.3.8.4 Strategic Initiatives
  • 11.3.9 PROTEINTECH GROUP, INC.
    • 11.3.9.1 Company Overview
    • 11.3.9.2 Financial Performance
    • 11.3.9.3 Product Benchmarking
    • 11.3.9.4 Strategic Initiatives
  • 11.3.10 JACKSON IMMUNORESEARCH INC.
    • 11.3.10.1 Company Overview
    • 11.3.10.2 Financial Performance
    • 11.3.10.3 Product Benchmarking
    • 11.3.10.4 Strategic Initiatives